Genomic mapping of metastatic organotropism in lung adenocarcinoma-Reference-Cited by-同舟云学术

Genomic mapping of metastatic organotropism in lung adenocarcinoma

Published:2023-05 Issue:5 Volume:41 Page:970-985.e3
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Lengel Harry B.,Mastrogiacomo Brooke,Connolly James G.,Tan Kay See,Liu Yuan,Fick Cameron N.,Dunne Elizabeth G.,He Di,Lankadasari Manendra B.,Satravada Baby Anusha,Sun Yichao,Kundra Ritika,Fong Chris,Smith Shaleigh,Riely Gregory J.,Rudin Charles M.,Gomez Daniel R.,Solit David B.,Berger Michael F.,Li Bob T.,Mayo Marty W.,Matei Irina,Lyden David C.,Adusumilli Prasad S.,Schultz Nikolaus,Sanchez-Vega Francisco,Jones David R.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference62 articles.

1. Emerging biological principles of metastasis;Lambert;Cell,2017

2. Patterns of recurrence and second primary lung cancer in early-stage lung cancer survivors followed with routine computed tomography surveillance;Lou;J. Thorac. Cardiovasc. Surg.,2013

3. Postoperative follow-up strategy based on recurrence dynamics for non-small-cell lung cancer;Watanabe;Eur. J. Cardio. Thorac. Surg.,2016

4. Outcomes after neoadjuvant or adjuvant chemotherapy for cT2-4N0-1 non-small cell lung cancer: a propensity-matched analysis;Brandt;J. Thorac. Cardiovasc. Surg.,2019

5. Update of incidence, prevalence, survival, and initial treatment in patients with non-small cell lung cancer in the US;Ganti;JAMA Oncol.,2021

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative analysis of PD-L1 expression and molecular alterations in primary versus metastatic lung adenocarcinoma: a real-world study in China;Frontiers in Oncology;2024-09-11

2. Spatial Immunogenomic Patterns Associated with Lymph Node Metastasis in Lung Adenocarcinoma;2024-09-03

3. Impact of lung adenocarcinoma subtypes on survival and timing of brain metastases;Frontiers in Oncology;2024-09-03

4. The Study of PIK3CA Hotspot Mutations and Co-Occurring with EGFR, KRAS, and TP53 Mutations in Non-Small Cell Lung Cancer;OncoTargets and Therapy;2024-09

5. Recent advances to address challenges in extracellular vesicle-based applications for lung cancer;Acta Pharmaceutica Sinica B;2024-09